Drug Discovery World

JUNE 30, 2023

News round-up for 26-30 June by DDW Digital Content Editor Diana Spencer. This week we have heard about a number of studies that demonstrate an inventive solution to an old problem, either through the use of an original approach or new, advanced technology. The top stories: Could a monoclonal antibody treat peanut allergy?

Allergies 52

Allergies Drugs Antibody Regulation 52

BioTech 365

JANUARY 27, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Making wheat and peanuts less allergenic.The United States Department of Agriculture identifies a group of “big eight” foods that causes 90% of food allergies.

Allergies 40

Allergies Research 40

pharmaphorum

OCTOBER 11, 2022

“Those affected by womb cancer deserve more treatment options, and today’s decision is very welcome news,” commented Dr Chloe Barr, trustee and advocacy lead at Peaches Womb Cancer Trust.

Allergies 52

Allergies Medicine Marketing 52

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100

Allergies FDA Approval Drugs Protein 100

pharmaphorum

AUGUST 5, 2020

DBV Technologies’ long and tortuous path to an FDA verdict on its Viaskin Peanut allergy shot has led to another dead end. The agency is asking for a new “human factor study” to examine how well the patch-based product adhere to the skin, and how that affects efficacy, according to DBV. Analysts think it should last into 2022.

Allergies 52

Allergies Production Clinical Trials Clinical Trials 52

pharmaphorum

DECEMBER 23, 2021

Children in England with peanut allergies could be among the first in Europe to get access to Aimmune’s oral immunotherapy Palforzia, after the drugmaker agreed a supply deal with NHS England. billion last year, is also developing immunotherapies for other indications including egg and multi-tree nut allergies.

Allergies 107

Allergies Drugs Clinical Trials Clinical Trials 107

Eye on FDA

JANUARY 11, 2021

Then in addition, FDA began issuing releases containing updates independently of the daily updates that relayed news of a special development. In late March FDA began issuing Coronavirus Updates labeled as a “Daily Roundup” except they weren’t actually always a daily release – some days got skipped.

Gene Therapy 66

Gene Therapy Vaccination Vaccine Allergies 66